Pharmaceutical Fraud
Serving Clients Nationwide in Qui Tam Cases, Fraud and Whistleblower Law
Kenney & McCafferty represents pharmaceutical employees, physicians, and other whistleblowers with knowledge of pharmaceutical fraud. This is a primary focus of our practice, and over the years we have helped recover billions of dollars for the federal government, netting our clients multi-million dollar whistleblower rewards.
The False Claims Act provides a strong financial incentive to individuals aware of pharmaceutical fraud to come forward with their information. The qui tam attorneys at Kenney & McCafferty have the skills and experience to help you prepare, investigate, and prosecute your claim to ensure the greatest likelihood that you will receive your reward.
There have been a growing number of pharmaceutical fraud whistleblower claims in recent years, resulting in the ongoing investigations of several hundred cases involving over 500 drugs by the Department of Justice. Since 1986, False Claims Act judgments and settlements have totaled over $20 billion, $3 billion of which has been recovered since January 2009 alone.
Types of Pharmaceutical Fraud
The vast majority of pharmaceutical fraud cases involve off-label marketing and pharmaceutical kickbacks. Off-label marketing refers to the practice of marketing a drug as being usable for purposes not approved by the FDA. These uses are not reimbursable through government programs such as Medicare or Medicaid. When the government subsidizes drugs due to their promotion for off-label uses, the pharmaceutical companies have committed fraud and can be held liable for these subsidies.
Pharmaceutical kickbacks are prohibited by federal law due to the risk that these kickbacks may compel a physician to prescribe a drug that will pad his bank account instead of a different drug which may be more effective for the patient. If you have knowledge of pharmaceutical kickback fraud, Kenney & McCafferty can help you bring a whistleblower lawsuit against the drug manufacturer.
Our qui tam lawyers also handle a variety of other pharmaceutical fraud cases, including:
- Good Manufacturing Practice (GMP) Violations
- Pharmaceutical Kickbacks
- Off-Label Marketing
- Best Price Fraud
- DESI Drugs
- Medicaid Price Reporting
- Manufactured Compound Drugs
- Off-Label Audits
- Medical Device and Medical Implant Fraud
- CME Fraud
A Track Record of Success
The attorneys at Kenney & McCafferty have been helping to blow the whistle on pharmaceutical fraud for over a decade. Notably, only a select few firms possess our extensive experience with these complex claims and, over the years, we have worked on some of the largest qui tam pharmaceutical fraud recoveries in the history of the False Claims Act, including:
- $2.3 billion settlement against Pfizer
- $1.3 billion settlement against Eli Lilly
These cases have resulted in millions of dollars in whistleblower rewards for our clients. If you have a pharmaceutical fraud qui tam case, Kenney & McCafferty can give you the greatest likelihood of a successful recovery.
If you have knowledge of a fraud or false claim against the government, please contact our qui tam lawyers today. Kenney & McCafferty attorneys will consult with you about your case, without obligation. All communications with Kenney & McCafferty attorneys during these consultation services are confidential and protected by the attorney-client privilege.
